Partner Anil Shankar was quoted in the Modern Healthcare article, “CMS Should Toss Proposed MFAR Rule, Experts Say,” about CMS’ proposed Medical Fiscal Accountability Rule and how its impairing the ability of states and safety-net providers to respond to the COVID-19 pandemic.
States are largely footing the bill for the many costs associated with treating COVID-19 amid a precipitous drop in tax revenues and a steep increase in unemployment and Medicaid enrollment. Last year, CMS proposed a rule that would increase the transparency of states’ supplemental payments to providers and limit how states can finance their Medicaid programs. While health care experts agree that more accountability is needed, many say CMS’ approach gives the agency too much power and the rule could have fallout. The pandemic has only increased those concerns.
MFAR may further complicate the Medicaid program. “It would be throwing additional fuel on what’s already a burning fire,” Shankar said. He suspects the rule will be back burnered due to the pandemic.
(Subscription required)
States are largely footing the bill for the many costs associated with treating COVID-19 amid a precipitous drop in tax revenues and a steep increase in unemployment and Medicaid enrollment. Last year, CMS proposed a rule that would increase the transparency of states’ supplemental payments to providers and limit how states can finance their Medicaid programs. While health care experts agree that more accountability is needed, many say CMS’ approach gives the agency too much power and the rule could have fallout. The pandemic has only increased those concerns.
MFAR may further complicate the Medicaid program. “It would be throwing additional fuel on what’s already a burning fire,” Shankar said. He suspects the rule will be back burnered due to the pandemic.
(Subscription required)
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”